Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh

NCT04402203 is registered in ClinicalTrials.gov with Bangladesh Medical Research Council (BMRC) as lead sponsor.

NCT NCT04402203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04402203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh
Lead sponsor
Bangladesh Medical Research Council (BMRC)
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 31, 2020
Completion date
July 31, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, favipiravir (favipira)